<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Medical: iStockAnalyst.com Feed</title>
    <link>http://www.istockanalyst.com</link>
    <description>iStockAnalyst.com Research, Blogs, Market Data and More</description>
    <generator>http://www.iStockAnalyst.com</generator>
    <pubDate>Mon, 30 Nov 2009 04:22:06 GMT</pubDate>
    <language>en</language>
    <ttl>30</ttl>
    <item>
      <title>Reducing National Health Care Spending</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3671021</guid>
      <description><![CDATA[Four researchers from RAND Health have an interesting article in the latest New England Journal of Medicine (ht Bruce Bartlett). Based on some detailed research in Massachusetts, they identified eight strategies that might help to reduce national health care spending:<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3671021>[More...]</a>]]></description>
      <pubDate>Sun, 29 Nov 2009 19:32:36 GMT</pubDate>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3671021</link>
    </item>
    <item>
      <title>Pfizer Adds R&amp;D Center In China</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3670462</guid>
      <description><![CDATA[Pfizer will expand its China R&amp;D operations by adding facilities in central and western China, according to a Reuters story. The company will build a new clinical R&amp;D center in Wuhan, which will support global clinical drug programs, including Phase I-IV clinical trials. Pfizer did not announce the size of capital commitment to the new R&amp;D center.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3670462>[More...]</a>]]></description>
      <pubDate>Sat, 28 Nov 2009 16:49:48 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3670462</link>
    </item>
    <item>
      <title>Cancer Vaccines: Investing Opportunities Beyond Dendreon (NASDAQ: DNDN)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3670454</guid>
      <description><![CDATA[Despite the setbacks and pitfalls experienced by early-stage pioneers in the cancer immunotherapy / therapeutic cancer vaccine space such as Cell Genesys, Favrille, and Genitope; recent advancements and study results are encouraging while Dendreon (NASDAQ: DNDN) awaits a FDA decision that is expected by May 2010 for its prostate cancer vaccine, Provenge, which is poised to become the first active cellular immunotherapy approved by the Agency to harness a patient's own immune system in the fight against the disease.



 

&#160;


 

Despite the setbacks and pitfalls experienced by early-stage pioneers in the cancer immunotherapy / therapeutic cancer vaccine space such as Cell Genesys, Favrille, and Genitope; recent advancements and study results are encouraging while Dendreon (NASDAQ: DNDN) awaits a FDA decision that is expected by May 2010 for its prostate cancer vaccine, Provenge, which is poised to become the first active cellular<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3670454>[More...]</a>]]></description>
      <pubDate>Sat, 28 Nov 2009 15:59:46 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ACI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AGEN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ASCO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CEGE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CRL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DNDN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DXG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">FVRL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GBM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GNSY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GTOP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IMUC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">INO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LRP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MNKD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MXM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NCI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PSA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">QTM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SCI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">UVV</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3670454</link>
    </item>
    <item>
      <title>Wall Street Slumps On Dubai Jitters, Alcoa (NYSE: AA) Slides</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3670447</guid>
      <description><![CDATA[US stocks finished lower in thin trade on Friday as worries about Dubai's financial trouble rattled investors.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3670447>[More...]</a>]]></description>
      <pubDate>Sat, 28 Nov 2009 15:45:51 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AIG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CAT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DYAX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TRV</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">XOM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3670447</link>
    </item>
    <item>
      <title>8 Penny Stock Watchlist From Friday</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3670445</guid>
      <description><![CDATA[Vermillion, Inc. (VRMLQ) filed their reorganization plans on Wednesday, good for them….the stock jumped a bit to $19, but the lack of any substantial volume means it’s a potential buy, but I’m sitting on the sidelines for now.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3670445>[More...]</a>]]></description>
      <pubDate>Sat, 28 Nov 2009 15:36:51 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BRYN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CLWT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DRAM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NLST</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">QLTI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SEED</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VRMLQ</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3670445</link>
    </item>
    <item>
      <title>Eight Stocks With Positive Dividend Momentum</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3669397</guid>
      <description><![CDATA[A body in motion tends to stay in motion unless acted on by an outside force. The following dividend payers kept the dividend momentum coming, by raising distributions to shareholders. What is particularly interesting is the fact that most of them have raised distributions consistently for more than one or two decades each.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3669397>[More...]</a>]]></description>
      <pubDate>Fri, 27 Nov 2009 16:03:03 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BDX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HRL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MKC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ORIT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RGC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RGCO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ROP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">UBSI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">YORW</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3669397</link>
    </item>
    <item>
      <title>BioMed Research Reports: Clinical Data (NASDAQ: CLDA), Lpath (OTC: LPTN.OB)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3669342</guid>
      <description><![CDATA[The BioMedReports.com research download section has been updated to include PDFs for two recent research reports written by Griffin Securities for Clinical Data (NASDAQ: CLDA) and Lpath, Inc. (OTC: LPTN.OB). Lpath received a buy rating with a $5 per share 12-month price target while CLDA was rated a buy with a 12-month price target of $38 per share. Below is a summary of both companies from their respective reports.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3669342>[More...]</a>]]></description>
      <pubDate>Fri, 27 Nov 2009 15:32:46 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CLDA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CRL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LPTN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SUP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3669342</link>
    </item>
    <item>
      <title>Sinovac Adds Vaccine Capacity by Forming JV</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3669291</guid>
      <description><![CDATA[Sinovac Biotech  announced a new Joint Venture, Sinovac (Dalian) Vaccine Technology Co., Ltd., that will research, develop and produce human vaccines. Sinovac will contribute its vaccine expertise and capital, while Dalian Jin Gang Group will throw in land use rights, manufacturing facilities and established operating infrastructure. Representatives of Sinovac will fill the major operational posts in the JV.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3669291>[More...]</a>]]></description>
      <pubDate>Fri, 27 Nov 2009 14:19:22 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">SVA</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3669291</link>
    </item>
    <item>
      <title>US Stock Futures Plunge On Dubai Woes, Financials Eyed</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3668517</guid>
      <description><![CDATA[US stock futures tumbled on Friday as investors remained worried about Dubai's debt crisis.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3668517>[More...]</a>]]></description>
      <pubDate>Fri, 27 Nov 2009 13:05:43 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AIG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DYAX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3668517</link>
    </item>
    <item>
      <title>Wall Street Ends Higher On Positive Data, Caterpillar (NYSE: CAT) Gains</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3666773</guid>
      <description><![CDATA[US stocks finished higher on Wednesday as better-than-expected economic data boosted investor optimism. Trading was relatively thin ahead of Thursday's US Thanksgiving holiday.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3666773>[More...]</a>]]></description>
      <pubDate>Wed, 25 Nov 2009 22:19:04 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CAT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DIS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KFT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TIF</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3666773</link>
    </item>
    <item>
      <title>Shanghai Biolaxy Given SFDA OK For Oral Insulin IND</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3666503</guid>
      <description><![CDATA[Shanghai Biolaxy received an SFDA approval of an investigational new drug application (IND) for its oral insulin product, Nodlin. Nodlin uses a patented bio-adhesive nano-particle oral delivery technology (NOD) to transport insulin through the stomach to the blood stream. No orally administered insulin drugs are approved currently.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3666503>[More...]</a>]]></description>
      <pubDate>Wed, 25 Nov 2009 20:25:14 GMT</pubDate>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3666503</link>
    </item>
    <item>
      <title>Hot Stocks Of The Day: HAL, CWTR, INCY, BNHNA, JCG</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3666211</guid>
      <description><![CDATA[US Stocks advanced Wednesday in thin trade as investors cheered upbeat unemployment and spending data.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3666211>[More...]</a>]]></description>
      <pubDate>Wed, 25 Nov 2009 18:11:13 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BNHNA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CWTR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HAL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">INCY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JCG</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3666211</link>
    </item>
    <item>
      <title>Turnaround Expert: 8 Stocks Below 1999 Highs</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3665455</guid>
      <description><![CDATA[&quot;We all know that, despite the big run-up recently, many stocks are still below their highs of a year or two ago,&quot; observes turnaround expert George Putnam.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3665455>[More...]</a>]]></description>
      <pubDate>Wed, 25 Nov 2009 17:17:49 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DIS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">INTC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WMT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WYE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3665455</link>
    </item>
    <item>
      <title>We Expect Ailing CROs To Recover</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3665046</guid>
      <description><![CDATA[If following the performance of contract research organizations (CROs) is like taking the temperature of the pharmaceutical industry, then drugmakers are still very much under the weather according to third-quarter results.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3665046>[More...]</a>]]></description>
      <pubDate>Wed, 25 Nov 2009 14:01:23 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CRL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ICLR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KNDL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PPDI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PRXL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3665046</link>
    </item>
    <item>
      <title>WPI: Financial Gauge Analysis For The September 2009 Quarter</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3664212</guid>
      <description><![CDATA[In a previous article, we examined Watson Pharmaceuticals' (NYSE: WPI) Income Statement for the third quarter of 2009 and compared the entries on each line to our &quot;look-ahead&quot; estimates.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3664212>[More...]</a>]]></description>
      <pubDate>Wed, 25 Nov 2009 03:45:55 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">WPI</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3664212</link>
    </item>
    <item>
      <title>Under The Radar Healthcare Stocks: Protox, Pressure BioSciences, Unilife</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3663651</guid>
      <description><![CDATA[Below are three under the radar stocks from the healthcare sector that I have been following for the past 3-6 months which have upcoming catalysts in the form of expected strategic deals, clinical trial results, and other corporate developments. Click here to check out my kaChing.com virtual investing portfolio, strategy, long / short virtual stock picks, and statistics since I started using the site in mid-April.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3663651>[More...]</a>]]></description>
      <pubDate>Tue, 24 Nov 2009 23:23:59 GMT</pubDate>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3663651</link>
    </item>
    <item>
      <title>Wall Street Ends Choppy Session Lower, Boeing (NYSE: BA) Falls</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3663543</guid>
      <description><![CDATA[US stocks finished lower on Tuesday after Federal Reserve upped its forecast for economic growth in 2010 but warned that jobless rate would likely remain high next year.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3663543>[More...]</a>]]></description>
      <pubDate>Tue, 24 Nov 2009 22:38:28 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HNZ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HPQ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HRL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JPM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MDT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">T</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VZ</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3663543</link>
    </item>
    <item>
      <title>Good News For Health Care Reform...</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3662866</guid>
      <description><![CDATA[But bad news for the American press. Ezra Klein and Stan Collender pile on to David Broder. Each day the Washington Post publishes David Broder is another day of humiliation for serious journalists working for the Post, for Newsweek, etc.--and also a day of humiliation for all those working for Stanley Kaplan Test Prep.



 

 

Stan Collender:



 

 

 

What Is David Broder Thinking?: David Broder has a column in today's The Washington Post that I find close to incomprehensible.&#160;

 First he says that<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3662866>[More...]</a>]]></description>
      <pubDate>Tue, 24 Nov 2009 18:54:58 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MXM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NNYP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WPO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3662866</link>
    </item>
    <item>
      <title>MIL Buys Remaining Stake in India</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3662803</guid>
      <description><![CDATA[Millipore Corp. (MIL) yesterday announced the acquisition of the remaining 60% ownership of its joint-venture in India, Millipore India Pvt. Ltd. The new subsidiary will enable Millipore to invest in initiatives that will drive growth and expand its leadership in India’s thriving life science market.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3662803>[More...]</a>]]></description>
      <pubDate>Tue, 24 Nov 2009 18:44:34 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">MIL</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3662803</link>
    </item>
    <item>
      <title>Hot Stocks Of The Day: ADI, AEO, MDT, BKS, BRCD</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3661738</guid>
      <description><![CDATA[US stocks declined on Tuesday as investors were disappointed by lackluster consumer confidence and third quarter GDP data.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3661738>[More...]</a>]]></description>
      <pubDate>Tue, 24 Nov 2009 17:34:47 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ADI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AEO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BKS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BRCD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MDT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3661738</link>
    </item>
    <item>
      <title>Twelve Recent Dividend Increasers</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3661473</guid>
      <description><![CDATA[Twelve companies last week raised distributions. While this is positive news in comparison to the avalanche of dividend cuts that were occurring just a few months ago, it is important that investors dig deeper into the numbers before they find out the next big thing.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3661473>[More...]</a>]]></description>
      <pubDate>Tue, 24 Nov 2009 15:23:29 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BF</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BOBE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EML</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HSC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">INTC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LANC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NKE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NST</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PNNT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RGLD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SYY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">UHS</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3661473</link>
    </item>
    <item>
      <title>Momentum Trading: Five Guidelines For Supercharging Your Portfolio With Momentum Stocks</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3661191</guid>
      <description><![CDATA[Momentum: Force or speed of movement. Impetus of a process, such as an idea, or course of events… That’s how the dictionary defines the word “momentum.”
We’ve all seen what can happen when an index, sector, or stock catches momentum – either to the upside or downside. However, momentum waves don’t move uniformly. They can bounce up and down in an upward trend, gradually making new highs and higher lows, or they can fall into a downward trend.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3661191>[More...]</a>]]></description>
      <pubDate>Tue, 24 Nov 2009 13:52:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CERN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ESI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">IMA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ISRG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ITT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NEU</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PLA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">QCOM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">YHOO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3661191</link>
    </item>
    <item>
      <title>7 Dividend Stocks To Take The Emotion Out Of Investing</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3661293</guid>
      <description><![CDATA[Deep-down in my soul, I am a contrarian. The third quarter market run-up converted most of the great dividend stock buys into ‘ok' buys (at best). As September came to a close, I felt a sense of excitement entering October. This is the month that stocks have traditionally gone on sale. I was prepared to make a double allocation (or more) depending on the level of the markets decline. It didn't happen.  Once again, investor emotions drove the market in an unpredictable direction.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3661293>[More...]</a>]]></description>
      <pubDate>Tue, 24 Nov 2009 13:48:11 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CLK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CTL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KMB</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MMM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PEP</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3661293</link>
    </item>
    <item>
      <title>US Stock Futures Mixed After GDP Data, HP (NYSE: HPQ) Eyed</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3661166</guid>
      <description><![CDATA[US stock futures pointed to a mixed open on Tuesday after a government release showed that US economy expanded at a 2.8% annualized rate in the third quarter.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3661166>[More...]</a>]]></description>
      <pubDate>Tue, 24 Nov 2009 12:42:50 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">HNZ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HPQ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HRL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MDT</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3661166</link>
    </item>
    <item>
      <title>Amylin Pharmaceuticals (NASDAQ: AMLN): Upgraded To Overweight At Barclays, Target Raised To $22</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3661161</guid>
      <description><![CDATA[Barclays is upgrading Amylin Pharmaceuticals (NASDAQ:AMLN) to Overweight from Equal-Weight with a $22 price target (prev. $16).
According to the firm, AMLN shares have been under pressure for several years, which they attribute to concerns regarding flattening Byetta trends, increasing competitive visibility, perceived regulatory risk for exenatide LAR, excess cash burn and limited pipeline visibility.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3661161>[More...]</a>]]></description>
      <pubDate>Tue, 24 Nov 2009 12:33:02 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMLN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3661161</link>
    </item>
    <item>
      <title>BioMed News Bytes: Transcept, ProUroCare, SciClone, ABIO</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3659922</guid>
      <description><![CDATA[On 11/23/09, Transcept Pharma (NASDAQ: TSPT) announced that it is scheduled to meet with the FDA on 1/20/10 to discuss the Complete Response Letter (CRL) regarding the New Drug Application (NDA) for Intermezzo (zolpidem tartrate sublingual tablet). As previously announced, the CRL, received by TSPT on 10/28/09, indicated that the FDA could not approve the NDA in its present form. The NDA seeks approval to market Intermezzo for use as-needed for the treatment of insomnia when a middle of the night awakening is followed by difficulty returning to sleep.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3659922>[More...]</a>]]></description>
      <pubDate>Mon, 23 Nov 2009 23:46:03 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABIO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CRL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DRE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SCLN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3659922</link>
    </item>
    <item>
      <title>Healthy Margins Of Safety Only</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3659537</guid>
      <description><![CDATA[As value investors, we often foray into areas of investment that nobody else will. Current earnings may be poor, the outlook uncertain, and the returns not expected for several years. In return for these sacrifices, we require one attribute on which we are unwilling to compromise: a large margin of safety.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3659537>[More...]</a>]]></description>
      <pubDate>Mon, 23 Nov 2009 20:54:04 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">INSM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3659537</link>
    </item>
    <item>
      <title>Hot Stocks Of The Day: CEPH, CI, CIEN, LDK, ZION</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3659258</guid>
      <description><![CDATA[US stocks were higher in midday trade as better-than-expected housing data reinforced hopes of strong economic recovery.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3659258>[More...]</a>]]></description>
      <pubDate>Mon, 23 Nov 2009 19:04:51 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CEPH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CIEN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LDK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ZION</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3659258</link>
    </item>
    <item>
      <title>Seven 5-Star Stocks From Berkshire's Latest Portfolio</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3658145</guid>
      <description><![CDATA[Burlington Northern was just one of several purchases Berkshire has made lately.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3658145>[More...]</a>]]></description>
      <pubDate>Mon, 23 Nov 2009 17:31:39 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AXP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BDX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BNI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CMCSK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ETN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KFT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MCO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NRG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NSRGY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RSG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">STI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TRV</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">UNH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WFC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WLP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WMT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WSC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">XOM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3658145</link>
    </item>
    <item>
      <title>Baxter (BAX): Bank On Blood Products</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3658061</guid>
      <description><![CDATA[&quot;Baxter International (NYSE: BAX)&#160;benefits from a robust balance sheet, solid operating momentum, and rising earnings estimates,&quot; says Richard Moroney.

In&#160;Dow Theory Forecasts, he explains, &quot;The ?rst company to commercially prepare intravenous treatments, Baxter has manufactured and distributed medical products since 1931.&quot; Here's his bullish<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3658061>[More...]</a>]]></description>
      <pubDate>Mon, 23 Nov 2009 16:47:16 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">BAX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3658061</link>
    </item>
    <item>
      <title>Technical Breakout Alert Issued For CytRx (NASDAQ:CYTR)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3657740</guid>
      <description><![CDATA[Miv Investments Inc. has initiated an independent bullish technical trading alert for 11/23/09 on CytRx Corporation (NASDAQ:CYTR). Shares of the company finished trading during 11/20/09 at $1.35 per share, up 20.18% from the opening bell on heavy buying pressure. As of 11/18/09, the biopharmaceutical company announced plans to initiate an open-label, multinational Phase 2 clinical trial with its doxorubicin prodrug INNO-206 as a second-line treatment in patients with advanced gastric (stomach) cancer.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3657740>[More...]</a>]]></description>
      <pubDate>Mon, 23 Nov 2009 13:57:08 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ACUS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ALXN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CLN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CYTR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DSCO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MDCO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MESA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NPHC</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3657740</link>
    </item>
    <item>
      <title>Diabetes Care: Global Investing Opportunities</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3657018</guid>
      <description><![CDATA[The American Diabetes Association estimates that there are currently 23.6 million diabetics in the U.S. (7.8% of the total population, including 17.9 million diagnosed cases, 5.7 million undiagnosed, and 57 million pre-diabetics. Diabetes results in an estimated $174 billion in costs from diagnosed cases of diabetes in the U.S. (2007).<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3657018>[More...]</a>]]></description>
      <pubDate>Mon, 23 Nov 2009 03:23:59 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ACCP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ALKS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMLN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ASX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BDX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CGM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CRL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DNA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DXCM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DXG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GLP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HDIX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MNKD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MXM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NKTR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NVO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RVP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TRIB</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VVUS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WST</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3657018</link>
    </item>
    <item>
      <title>The Week In Review: CROs Consolidating</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3657011</guid>
      <description><![CDATA[PPD, Inc. will acquire BioDuro, a preclinical CRO, as a follow-up to its purchase last month of Excel PharmaStudies, both of which are major transactions;&#160;we reflected on the huge difference between how China and the US go about creating “life science clusters”; China enrolled&#160;a record number of students in American universities during 2008-9; China Cord Blood listed on the&#160;NYSE and also completed a secondary offering; Advanced BioMedical&#160;signed an agreement in China&#160;to develop its bio-absorbable material in new applications;<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3657011>[More...]</a>]]></description>
      <pubDate>Mon, 23 Nov 2009 03:05:55 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AOB</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CHME</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MDCO</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">OCLS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PPD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PPDI</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SVA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TCM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3657011</link>
    </item>
    <item>
      <title>GSK To Manufacture Flu Treatment Relenza In China</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3655130</guid>
      <description><![CDATA[GlaxoSmithKline will begin manufacturing its treatment for flu, Relenza, in China to supply China’s domestic market. GSK received approval of the drug in September from the SFDA. Relenza, like Tamiflu from Roche, aims at reducing both the severity and the duration of flu symptoms, though some resistance to the drugs&#160;seems to be&#160;evident.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3655130>[More...]</a>]]></description>
      <pubDate>Fri, 20 Nov 2009 20:49:03 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">GSK</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3655130</link>
    </item>
    <item>
      <title>Blue-Chip Biotechs Maneuver To Collect Monopoly Profits: AMGN, BIIB, GENZ</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3654885</guid>
      <description><![CDATA[By Dr. George Huang
It's hard to find winners in the nightmarish health care reform bill passed by the House...
The bill doesn't address the major complaint of the American consumers – soaring costs. In fact, health insurers already predict skyrocketing premiums next year. Instead, the bill forces most employers to provide health care coverage or pay a tax penalty of up to 8% of payroll. The added cost will crush many small businesses.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3654885>[More...]</a>]]></description>
      <pubDate>Fri, 20 Nov 2009 19:06:25 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GENZ</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3654885</link>
    </item>
    <item>
      <title>BioMed News Bytes: CombinatoRx, Dendreon, Photocure, Pozen</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3654880</guid>
      <description><![CDATA[On 11/2/09, Dendreon (NASDAQ: DNDN) announced that it has completed the submission of its amended Biologics License Application (BLA) for PROVENGE (sipuleucel-T), seeking approval for men with metastatic castrate-resistant prostate cancer (CRPC). The amended BLA includes data from the IMPACT trial, which was conducted under a Special Protocol Assessment agreement with the FDA. The IMPACT study met its pre-specified primary endpoint demonstrating a statistically significant improvement in overall survival in men with metastatic CRPC.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3654880>[More...]</a>]]></description>
      <pubDate>Fri, 20 Nov 2009 19:03:44 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">CRL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CRXX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DNDN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">POZN</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3654880</link>
    </item>
    <item>
      <title>Technical Trading Alert For Echo Therapeutics (OTC: ECTE.OB)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3654033</guid>
      <description><![CDATA[MivInvestments Inc. has initiated an independent bullish technical trading alert for 11/20/09 on Echo Therapeutics, Inc. (OTC:ECTE.OB). Shares of the company finished the day at $1.35, up 8.15% from the opening bell on heavy buying pressure. The excitement was due to the announcement on positive results of a clinical study testing symphony(TM) tCGM System in Patients with Type 1 and Type 2 Diabetes. Despite the fact that there has been a recent common shares financing scheduled, companies usually take their time and let the price consolidate before engaging in these activities, thus a short-term buy could be a smart investment. Towards the end of this alert a technical analysis will also be issued.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3654033>[More...]</a>]]></description>
      <pubDate>Fri, 20 Nov 2009 17:13:16 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ECTE.OB</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3654033</link>
    </item>
    <item>
      <title>Obama's Flawed Prescription For Health Care</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3651940</guid>
      <description><![CDATA[The House of Representatives has already passed its health-care bill and now the Senate is preparing to vote on its own. Should it pass, the largest new entitlement program since the New Deal will be a reconciliation process and a President’s signature away from being enacted. This is Congress and President Obama’s proposed cure for the ills of our health-care system. But are we sure they have properly diagnosed the disease?<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3651940>[More...]</a>]]></description>
      <pubDate>Thu, 19 Nov 2009 21:13:56 GMT</pubDate>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3651940</link>
    </item>
    <item>
      <title>The Problem with Our Health-Care Debate</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3651882</guid>
      <description><![CDATA[Everyone seems to have a different take on how to solve America’s health-care problem. But notice that every solution offered involves some elaborate new system of government controls. Different proposals include a “public option,” mandatory insurance for individuals, government-supported health-care exchanges, government-sponsored “efficacy research,” government-supported co-ops, and as many other ways of dictating consumer and producer behavior as can fit in a 1,000-page bill.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3651882>[More...]</a>]]></description>
      <pubDate>Thu, 19 Nov 2009 20:55:37 GMT</pubDate>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3651882</link>
    </item>
    <item>
      <title>Goldman Sachs Puts Pfizer’s 2012 China Sales At $3 Billion</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3651721</guid>
      <description><![CDATA[In an investment review of Pfizer, Goldman Sachs said&#160;sales in emerging growth markets would become a significant factor in the company’s revenues, a fact that it considers underappreciated by stock market investors. China is the major emerging market for Pfizer. Goldman expects emerging growth markets to produce $3.5 billion of revenue for Pfizer in 2012, and $3 billion of that will come from China.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3651721>[More...]</a>]]></description>
      <pubDate>Thu, 19 Nov 2009 20:08:19 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">GS</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3651721</link>
    </item>
    <item>
      <title>Options Intelligence Report: GAO Report Boosts Fortunes Of Credit Card Companies</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3650471</guid>
      <description><![CDATA[Today's tickers: MA, V, RF, KG, HW, WSM, AEP &amp; NTAP<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3650471>[More...]</a>]]></description>
      <pubDate>Thu, 19 Nov 2009 17:58:49 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AEP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">HW</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">KG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MA</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NTAP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">RF</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">V</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">WSM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3650471</link>
    </item>
    <item>
      <title>BioMed News Bytes: AstraZeneca, Delcath, Unilife</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3650316</guid>
      <description><![CDATA[On 11/19/09, AstraZeneca (NYSE: AZN) announced the submission of a New Drug Application (NDA) to the FDA for ticagrelor, an investigational oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndrome (ACS). The proposed trade name for ticagrelor is BRILINTA, pending approval from the FDA. This submission is based on the results of a comprehensive program, including data from PLATO (A Study of Platelet Inhibition and Patient Outcomes), the Phase 3 head-to-head trial comparing ticagrelor plus aspirin with clopidogrel (Plavix) plus aspirin. Ticagrelor is the first reversibly binding oral P2Y12 adenosine<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3650316>[More...]</a>]]></description>
      <pubDate>Thu, 19 Nov 2009 16:48:58 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CRL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DCTH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3650316</link>
    </item>
    <item>
      <title>Epinex Diagnostics: A New Paradigm For Diabetic Testing</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3650097</guid>
      <description><![CDATA[Epinex Diagnostics Inc. (click on preceding link for the Company's News Room page) is a private company that is&#160;dedicated to the development of innovative point-of-care technologies using rapid diagnostic tests. Epinex has developed a proprietary platform for rapid tests that apply existing immunoassay strips and biosensors to create unique quantitative diagnostic tests.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3650097>[More...]</a>]]></description>
      <pubDate>Thu, 19 Nov 2009 15:19:29 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3650097</link>
    </item>
    <item>
      <title>Micro-Cap Announces Strong Nine Month Revenue Results (ISCR.OB)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3650083</guid>
      <description><![CDATA[The debate has reached loud and harsh levels when it comes to health-care in the United States and who should provide it. But folks on both the left and the right appear to agree on one thing: keeping our bodies sound costs too much, and – just perhaps – there is a place for companies in the private sector to keep those costs on a reasonable plane. One company seems to have gotten that efficiency message, and looks to have been amply rewarded for it.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3650083>[More...]</a>]]></description>
      <pubDate>Thu, 19 Nov 2009 15:15:00 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ISCR.OB</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3650083</link>
    </item>
    <item>
      <title>Volume Talks: Hot Stocks On Heavy Volume &amp; Detailed Earnings Option Trade</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3649972</guid>
      <description><![CDATA[In this post, I will name 25 stocks which traded higher Wednesday November 18, 2009 on unusually higher volume. As always, I will keep an eye on these stocks Thursday to see if there is continued buying pushing the stocks higher. This method is just one of the ways I use to pick stocks to structure particular option trades. The second part of this post requires the knowledge of stock options.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3649972>[More...]</a>]]></description>
      <pubDate>Thu, 19 Nov 2009 14:24:50 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">SIRO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3649972</link>
    </item>
    <item>
      <title>Options Intelligence Report: Eager Call Option Buyers At Bunge Sitting Pretty</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3647683</guid>
      <description><![CDATA[Today’s tickers: BG, ILMN, COH, TMO, SPG, BG, ADSK &amp; SLM<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3647683>[More...]</a>]]></description>
      <pubDate>Wed, 18 Nov 2009 18:25:35 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ADSK</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">BG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">COH</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ILMN</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SLM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">SPG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">TMO</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3647683</link>
    </item>
    <item>
      <title>A Winning Investment Strategy</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3646237</guid>
      <description><![CDATA[We all want to succeed in everything that we do, including investing in the stock market. Though I have no analytical data to back it up, I am convinced that most people will lose money in the stock market over their lifetime. So why do so few people succeed at investing? Could it be that an individual's desire to succeed be a significant reason for their failure.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3646237>[More...]</a>]]></description>
      <pubDate>Wed, 18 Nov 2009 15:39:58 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">ABT</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">ADP</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">AFL</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">CVX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">DOV</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">EMR</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">GPC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">INTC</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MCD</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">MMM</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">NUE</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PG</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">UTX</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3646237</link>
    </item>
    <item>
      <title>Power3 Investors Feeling Bullish Prior To Expo (OTC: PWRM.OB)</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3646059</guid>
      <description><![CDATA[Miv Investments Inc. has initiated an independent bullish technical trading alert for 11/18/09 on Power3 Medical Products, Inc. (OTC:PWRM.OB). Shares of the company finished the day at $0.129, up 69.74% from the opening bell on heavy buying pressure. The spark which ignited the rise in share price is being speculated as being attributed due to the&#160; BTI Life Sciences 2nd Annual<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3646059>[More...]</a>]]></description>
      <pubDate>Wed, 18 Nov 2009 13:54:21 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">PWRM</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3646059</link>
    </item>
    <item>
      <title>Is This The Next "Vermillion Dollar Baby?"</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3646054</guid>
      <description><![CDATA[No conversation about blood diagnostic stocks is complete without first discussing what many biotech investors call the &quot;Vermillion Dollar baby.&quot; So before we talk about PWRM, let's put things into perspective and start there.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3646054>[More...]</a>]]></description>
      <pubDate>Wed, 18 Nov 2009 13:50:22 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">GHDX</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">PWRM.OB</category>
      <category domain="http://rss.financialcontent.com/stocksymbol">VRMLQ.OB</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3646054</link>
    </item>
    <item>
      <title>Is Viking Systems (OTC:VKNG) Done Running Yet?</title>
      <guid>http://www.istockanalyst.com/article/viewarticle/articleid/3644621</guid>
      <description><![CDATA[The forward looking news items are still ahead and from a technical analysis stand point, things still look relatively bullish.<a href=http://www.istockanalyst.com/article/viewarticle/articleid/3644621>[More...]</a>]]></description>
      <pubDate>Wed, 18 Nov 2009 00:13:04 GMT</pubDate>
      <category domain="http://rss.financialcontent.com/stocksymbol">VKNG.OB</category>
      <link>http://www.istockanalyst.com/article/viewarticle/articleid/3644621</link>
    </item>
    <atom:link href="http://www.istockanalyst.com/widget/rssfeed.aspx?zone=Medical" rel="self" type="application/rss+xml" />
  </channel>
</rss>